It’s a move that will help the company expand into Europe, Africa and Middle East.
“The combination of Aphria and Nuuvera creates a true global leader in medical cannabis with excellent potential for growth and value creation,” Aphria CEO Vic Neufeld said in a news release.
“This transaction, which builds on a long-standing relationship between the two companies, brings together our top tier ability to grow high-quality cannabis at a low-cost with Nuuvera’s expansive international network, expertise in processing, and access to industry leading technology,” says Neufeld.
The deal builds on a partnership between the companies as it combines Aphria’s production with Nuuvera’s expertise in cannabis processing and extraction. The combination will also help grow Aphria’s international footprint.
credit:iheartradio.ca